drugset / Trial / NCT02437032

Gonadotropin Type in Ovarian Stimulation

NCT02437032

Phase 4 Completed 100 enrolled IVI Madrid
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A key challenge facing reproductive biologists is the integration of the knowledge about oocyte-secreted factors into coherent physiological mechanisms of how oocytes govern folliculogenesis, cumulus cell function, and oocyte and embryo development. Although key oocyte-secreted factors have been identified, understanding their modes of action is complicated by multiple interactions between maternal and oocyte signaling molecules, as well as the constantly changing state of physical interactions between the oocyte and its companion somatic cells during folliculogenesis. Thus, the investigators study aimed to determine if there is any relationship between different gonadotropin preparations and oocyte-secreted factor secretion, the endocrine pattern in follicular fluid, and the apoptotic rate in cumulus cells during controlled ovarian stimulation.

Timeline

Start
2009-04
Primary completion
2012-09
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bravelle Unknown
Comparator Gonal-f Protein / enzyme biologic
Comparator hMG Unknown

Indications